Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 6, 2009
Mon, October 5, 2009 TER, CNO, FAF, SGEN, RT, KOF Expected To Be Lower Leading Up To Next Earnings Releases
October 6, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and October/November earnings reports. Teradyne (NYSE: TER), Conseco (NYSE: CNO), First American Corp (NYSE: FAF), Seattle Genetics (NASDAQ: SGEN), Ruby Tuesday (NYSE: RT) and Coca-Cola FEMSA (NYSE: KOF) are all expected to be lower leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower leading up to their next earnings release:
Symbol Company # of Reports Quarter Release Date
TER Teradyne Inc. 12 quarters Q3 10/21/2009
CNO Conseco, Inc. 12 quarters Q3 11/5/2009
FAF The First American Corp 12 quarters Q3 10/29/2009
SGEN Seattle Genetics Inc. October earnings Q3 10/22/2009
RT Ruby Tuesday, Inc. 12 quarters Q1 10/7/2009
KOF Coca-Cola FEMSA SA October earnings Q3 10/22/2009
Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
Teradyne, Inc. (NYSE: TER), together with its subsidiaries, provides automatic test equipment products and services worldwide. The company operates in two segments, Semiconductor Test and Systems Test Group. The Semiconductor Test segment engages in the design, manufacture, and marketing of semiconductor test products and services. Its test systems are used for wafer level and device package testing. These chips are used in automotive, communications, consumer, computer, and electronic game applications. This segment provides its products to integrated device manufacturers (IDMs) that integrate the fabrication of silicon wafers into their business, aFablessa� companies that outsource the manufacturing of silicon wafers, aFoundriesa� that cater to the processing and manufacturing of silicon wafers, and outsourced semiconductor assembly and test companies that provide test and assembly services for the final packaged devices to both Fabless companies and IDMs. It also provides Magnum test platform that tests memory devices, such as flash memory and dynamic random access memory, which are used in electronic products, as well as offers ETS platform for use by semiconductor manufacturers and assembly and test subcontractors in the low pin count analog/mixed signal discrete markets. The Systems Test Group segment involves in the design, manufacture, and marketing of circuit-board test and inspection, military/aerospace instrumentation test, and automotive diagnostic and test products and services. This segment markets its products to the electronics manufacturers of cell phones, servers, computers, Internet switches, automobiles, and military avionics systems. Teradyne has a strategic alliance with OptimalTest Ltd. to offer a set of semiconductor test solutions. The company was founded in 1960 and is based in North Reading, Massachusetts.
Conseco, Inc. (NYSE: CNO), through its subsidiaries, engages in the development, marketing, and administration of supplemental health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. The company operates in three segments: Bankers Life, Colonial Penn, and Conseco Insurance Group. The Bankers Life segment markets and distributes Medicare supplement insurance, life insurance, long-term care insurance, Medicare part D prescription drug program, Medicare advantage products, and certain annuity products through career agents and sales managers. The Colonial Penn segment markets primarily graded benefit and simplified issue life insurance directly to customers through television advertising, direct mail, Internet, and telemarketing. The Conseco Insurance Group segment markets and distributes specified disease insurance, Medicare supplement insurance, and various life and annuity products through independent marketing organizations. This segment markets its products under the Conseco and Washington National brand names. The company also offers reinsurance products. It also sells products through professional independent producers and direct marketing. Conseco, Inc. has a strategic alliance with Coventry Health Care. The company was founded in 1979 and is headquartered in Carmel, Indiana.
The First American Corporation (NYSE: FAF), through its subsidiaries, provides business information and related products and services in the United States. Its Title Insurance and Services segment issues residential and commercial title insurance policies; and provides related escrow services and accommodates tax-deferred exchanges, as well as offers investment advisory services, trust services, lending and deposit products, and other related products and services. The companya�s Specialty Insurance segment issues property and casualty insurance policies, and sells home warranty products. Its Information and Outsourcing Solutions segment provides tax monitoring, flood zone certification and monitoring, building and maintaining geospatial proprietary software and databases, default management services, loan administration and production services, business process outsourcing, and asset valuation and management services. The companya�s Data and Analytic Solutions segment offers licenses and analyzes data relating to mortgage securities and loans, and real property; risk management and collateral assessment analytics; and database access tools and automated appraisal services. Its Risk Mitigation and Business Solutions segment provides consumer credit reporting solutions for mortgage and home equity needs, transportation credit reporting, motor vehicle record reporting, criminal records reselling, specialty finance credit reporting, consumer credit reporting, lead generation, consumer credit reports and automotive lead development services for the automotive dealer marketplace, employment background screening, hiring management solutions, occupational health, tax incentive, payroll and human resource management, resident screening, property management software, rentersa� insurance, computer forensics, electronic discovery, data recovery, due diligence reporting, and corporate and litigation investigative services. The company was founded in 1894 and is based in Santa Ana, California.
Seattle Genetics, Inc. (NASDAQ: SGEN), a clinical-stage biotechnology company, focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. Its lead product, SGN-35, is in pivotal trial for patients with relapsed or refractory hodgkin lymphoma under a special protocol assessment. The companya�s other product candidates in various stages of clinical trials include dacetuzumab (SGN-40), a humanized anti-CD40 antibody; lintuzumab (SGN-33), a humanized anti-CD33 antibody; and SGN-70, a humanized anti-CD70 antibody. In addition, its product candidates in development comprise SGN-75 for CD70-positive hematologic malignancies and solid tumors; AGS-5ADC for solid tumors; and SGN-19A for CD19-positive hematologic malignancies. It has a collaboration agreement with Genentech, Inc. to develop and commercialize Dacetuzumab; with Genentech, Inc., Bayer Pharmaceuticals Corporation, CuraGen Corporation, Progenics Pharmaceuticals, Inc., Daiichi Sankyo Co., Ltd., and MedImmune Inc. for the companya�s antibody-drug conjugates (ADC) technology; and an ADC co-development agreement with Agensys, Inc. The company was founded in 1997 and is headquartered in Bothell, Washington.
Ruby Tuesday, Inc. (NYSE: RT), together with its subsidiaries, engages in the development, operation, and franchise of casual dining restaurants under the Ruby Tuesday brand name in the United States and internationally. As of June 3, 2008, the company owned and operated 721 casual dining restaurants; franchise partnerships operated 122 restaurants; and traditional franchisees operated 48 domestic and 54 international restaurants in the United States, the Asia Pacific Region, India, the Middle East, Puerto Rico, Guam, Canada, Iceland, eastern Europe, and Central and South America. The company was founded in 1920 and is based in Maryville, Tennessee.
Coca-Cola FEMSA S.A.B de C.V. (NYSE: KOF) engages in the production, distribution, and marketing of Coca-Cola trade beverages. It offers Coca-Cola, Sprite, Fanta, Lift, and other trademark beverages of The Coca-Cola Company in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, and Argentina, as well as bottled water, beer, and other beverages. The company was founded in 1979 and is headquartered in Mexico City, Mexico. Coca-Cola FEMSA S.A.B de C.V. operates as a subsidiary of Fomento Economico Mexicano, S.A.B. de C.V.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com
Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
